Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hypertension
  Free Subscription

Articles published in
Curr Opin Nephrol Hypertens
    April 2024
  1. DISSANAYAKE LV, Palygin O, Staruschenko A
    Lysine and salt-sensitive hypertension.
    Curr Opin Nephrol Hypertens. 2024 Apr 22. doi: 10.1097/MNH.0000000000000994.
    >> Share

    March 2024
  2. AL-HOSNI R, Kaye R, Choi CS, Tammaro P, et al
    The TMEM16A channel as a potential therapeutic target in vascular disease.
    Curr Opin Nephrol Hypertens. 2024;33:161-169.
    >> Share

    January 2024
  3. DEMIRCI M, Hinton A, Kirabo A
    Dendritic cell epithelial sodium channel induced inflammation and salt-sensitive hypertension.
    Curr Opin Nephrol Hypertens. 2024 Jan 8. doi: 10.1097/MNH.0000000000000963.
    >> Share

  4. BENSON LN, Mu S
    Interferon gamma in the pathogenesis of hypertension - recent insights.
    Curr Opin Nephrol Hypertens. 2024 Jan 5. doi: 10.1097/MNH.0000000000000966.
    >> Share

  5. ALVAREZ-ELIAS AC, Brenner BM, Luyckx VA
    Climate change and its influence in nephron mass.
    Curr Opin Nephrol Hypertens. 2024;33:102-109.
    >> Share

    November 2023
  6. TANTISATTAMO E, Ferrey AJ, Reddy UG, Malik FT, et al
    A paradigm shift from office to home-based blood pressure measurement approaches in kidney transplant recipients.
    Curr Opin Nephrol Hypertens. 2023 Nov 9. doi: 10.1097/MNH.0000000000000951.
    >> Share

  7. LUCAS B, Taal MW
    Blood pressure targets in chronic kidney disease: still no consensus.
    Curr Opin Nephrol Hypertens. 2023;32:497-501.
    >> Share

    September 2023
  8. CAMAFORT M, Ihm SH, Ruilope LM
    Renal denervation for the treatment of hypertension and kidney disease.
    Curr Opin Nephrol Hypertens. 2023 Sep 14. doi: 10.1097/MNH.0000000000000928.
    >> Share

  9. MAGANA-AVILA GR, Castaneda-Bueno M
    Role of NCC in the pathophysiology of hypertension in primary aldosteronism.
    Curr Opin Nephrol Hypertens. 2023;32:476-481.
    >> Share

  10. CHAVEZ-CANALES M, Garcia JA, Gamba G
    Regulation of the WNK4-SPAK-NCC pathway by the calcium-sensing receptor.
    Curr Opin Nephrol Hypertens. 2023;32:451-457.
    >> Share

  11. DRAWZ P, Baumann D, Dayton A
    Renal denervation: recent developments in clinical and preclinical research.
    Curr Opin Nephrol Hypertens. 2023;32:404-411.
    >> Share

    June 2023
  12. KOTTA PA, Nambi V
    Biomarker guided management of hypertension.
    Curr Opin Nephrol Hypertens. 2023 Jun 12. doi: 10.1097/MNH.0000000000000905.
    >> Share

    May 2023
  13. ABBASI M, Teakell J
    Literature review: are NSAIDs harmful and is acetaminophen well tolerated?
    Curr Opin Nephrol Hypertens. 2023;32:284-289.
    >> Share

    April 2023
  14. CORNELIUS RJ, Maeoka Y, McCormick JA
    Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension.
    Curr Opin Nephrol Hypertens. 2023 Apr 13. doi: 10.1097/MNH.0000000000000891.
    >> Share

    March 2023
  15. HEBERT JF, Funahashi Y, Hutchens MP
    Harm! foul! How acute kidney injury SHReDDs patient futures.
    Curr Opin Nephrol Hypertens. 2023;32:165-171.
    >> Share

  16. GUPTA S, Petras L, Tufail MU, Rodriguez Salazar JD, et al
    Hypertension in Pregnancy: What We Now Know.
    Curr Opin Nephrol Hypertens. 2023;32:153-164.
    >> Share

  17. AVVISATO R, Jankauskas SS, Varzideh F, Kansakar U, et al
    Sortilin and hypertension.
    Curr Opin Nephrol Hypertens. 2023;32:134-140.
    >> Share

  18. VATISH M, Powys VR, Cerdeira AS
    Novel therapeutic and diagnostic approaches for preeclampsia.
    Curr Opin Nephrol Hypertens. 2023;32:124-133.
    >> Share

  19. MELLOTT E, Faulkner JL
    Mechanisms of leptin-induced endothelial dysfunction.
    Curr Opin Nephrol Hypertens. 2023;32:118-123.
    >> Share

    December 2022
  20. DEUSSEN A, Kopaliani I
    Targeting inflammation in hypertension.
    Curr Opin Nephrol Hypertens. 2022 Dec 8. doi: 10.1097/MNH.0000000000000862.
    >> Share

    September 2022
  21. EHRET E, Hummler E
    Lessons learned about epithelial sodium channels from transgenic mouse models.
    Curr Opin Nephrol Hypertens. 2022;31:493-501.
    >> Share

  22. ALI S, Navaneethan SD, Virani SS, Gregg LP, et al
    Revisiting diuretic choice in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2022;31:406-413.
    >> Share

    July 2022
  23. GEORGIANOS PI, Agarwal R
    Management of hypertension in advanced kidney disease.
    Curr Opin Nephrol Hypertens. 2022;31:374-379.
    >> Share

    March 2022
  24. ABU SALMAN L, Cohen JB
    Updates in hypertension: new trials, targets and ways of measuring blood pressure.
    Curr Opin Nephrol Hypertens. 2022 Mar 4. pii: 00041552-900000000-98929.
    >> Share

  25. DIKALOV S, Dikalova A
    Mitochondrial deacetylase Sirt3 in vascular dysfunction and hypertension.
    Curr Opin Nephrol Hypertens. 2022;31:151-156.
    >> Share

    November 2021
  26. HANNA RM, Ahdoot RS, Kim MS, Jhaveri KD, et al
    Intravitreal vascular endothelial growth factors hypertension, proteinuria, and renal injury: a concise review.
    Curr Opin Nephrol Hypertens. 2021 Nov 8. pii: 00041552-900000000-98951.
    >> Share

  27. TANTISATTAMO E, Hamiduzzaman A, Sohn P, Ahdoot R, et al
    Reconciling Systolic Blood Pressure Intervention Trial with Eighth Joint National Commission: a nuanced view of optimal hypertension control in the chronic kidney disease population.
    Curr Opin Nephrol Hypertens. 2021 Nov 5. pii: 00041552-900000000-98955.
    >> Share

    May 2021
  28. HUNDEMER GL, Kline GA, Leung AA
    How common is primary aldosteronism?
    Curr Opin Nephrol Hypertens. 2021;30:353-360.
    >> Share

    January 2021
  29. KOURI AM, Rheault MN
    Cardiovascular disease in children with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 Jan 13. pii: 00041552-900000000-99002.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016